Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 01, 2006 (Vol. 26, No. 7)

Commercial Amounts of Purine Nucleosides

Metkinen Chemistry Applies Biotransformation Technology to Control and Improve Costs

  • Metkinen Chemistry (www.metkinenchemistry.com) recently unveiled a biotransformation technology that, the company says, has enabled for the first time the cost-effective commercial production of purine nucleoside analogues for use in the development of oligonluceotide therapeutics and for research applications. Metkinen is a Finnish company that develops and markets reagents ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.